yttrium radioisotopes has been researched along with Cancer, Second Primary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adamo, RD; Anne, PR; Chervoneva, I; Eschelman, DJ; Gonsalves, CF; Hage, AN; Orloff, MM; Sato, T; Terai, M; Yi, M | 1 |
| Arnold, D; Bilbao, JI; Bouvier, A; Greget, M; Helmberger, T; Kaufmann, N; Loffroy, R; Maleux, G; Mastier, C; Pelage, JP; Pellerin, O; Peynircioglu, B; Ronot, M; Sangro, B; Schaefer, N; Sengel, C; Tselikas, L; Urdániz, M; Vilgrain, V | 1 |
| Ansell, SM; Burnette, BL; Colgan, JP; Epperla, N; Habermann, TM; Inwards, DJ; Johnston, PB; Macon, WR; Markovic, SN; Micallef, IN; Nowakowski, GS; Pham, AQ; Porrata, LF; Ristow, KM; Wiseman, GA; Witzig, TE | 1 |
| Bischof-Delaloye, A; Botto, B; Hagenbeek, A; Kylstra, JW; Morschhauser, F; Radford, J; Rohatiner, AZ; Salles, G; Soubeyran, P; Tilly, H; Van Hoof, A; van Putten, WL | 1 |
| Andrade-Campos, MM; Baringo, T; Giraldo, P; Grasa, JM; Lopez-Gómez, L; Montes-Limón, AE; Soro-Alcubierre, G | 1 |
| Dobrocky, T; Fuerstner, M; Kara, L; Klaeser, B; Lopez-Benitez, R; Wälti, YB | 1 |
| Buttiglieri, S; Carlo-Stella, C; Devizzi, L; Di Nicola, M; Giacomini, A; Gianni, AM; Guidetti, A; Locatelli, SL; Mariani, L; Miceli, R; Passera, R; Risso, A; Ruella, M; Tarella, C; Testi, A | 1 |
| Berger, L; Brans, B; Bucerius, J; Mottaghy, FM; Prompers, L; Temur, Y | 1 |
| Dewald, G; Gordon, LI; Kent, SA; Multani, P; Nabhan, C; Peterson, LA; Tallman, MS | 1 |
| HAYEM, M; JURET, P | 1 |
| Borghaei, H; Schilder, RJ; Wallace, SG | 1 |
| Boni, G; Cecconi, N; Focosi, D; Galimberti, S; Orciuolo, E; Petrini, M | 1 |
2 review(s) available for yttrium radioisotopes and Cancer, Second Primary
| Article | Year |
|---|---|
Selective internal radiation therapy (SIRT) in primary or secondary liver cancer.
Topics: Animals; Brachytherapy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasms, Second Primary; Radionuclide Imaging; Yttrium Radioisotopes | 2011 |
Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antigens, CD20; Humans; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Prognosis; Radioimmunotherapy; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2004 |
3 trial(s) available for yttrium radioisotopes and Cancer, Second Primary
| Article | Year |
|---|---|
A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
Topics: Diagnostic Imaging; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2019 |
90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Disease-Free Survival; Female; Follow-Up Studies; Humans; International Cooperation; Kaplan-Meier Estimate; Lymphoma, Follicular; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radioimmunotherapy; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Topics: Adult; Aged; Antibodies, Monoclonal; Bone Marrow; Female; Follow-Up Studies; Granulocyte-Macrophage Progenitor Cells; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radioimmunotherapy; Risk; Telomere; Yttrium Radioisotopes | 2011 |
7 other study(ies) available for yttrium radioisotopes and Cancer, Second Primary
| Article | Year |
|---|---|
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; France; Humans; Incidence; Liver Neoplasms; Male; Neoplasms, Second Primary; Quality of Life; Yttrium Radioisotopes | 2021 |
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Databases, Factual; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radioimmunotherapy; Risk Factors; Rituximab; Vidarabine; Young Adult; Yttrium Radioisotopes | 2017 |
Long-term efficacy of (90)Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; Antigens, Neoplasm; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neutropenia; Quality of Life; Radioimmunotherapy; Remission Induction; Rituximab; Thrombocytopenia; Yttrium Radioisotopes | 2014 |
Regional Radiation Pneumonitis After SIRT of a Subcapsular Liver Metastasis: What is the Effect of Direct Beta Irradiation?
Topics: Adult; Biopsy; Female; Follow-Up Studies; Humans; Leiomyosarcoma; Liver Neoplasms; Lung; Microspheres; Monte Carlo Method; Neoplasms, Second Primary; Radiation Pneumonitis; Tomography, X-Ray Computed; Vascular Neoplasms; Yttrium Radioisotopes | 2015 |
Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antigens, CD20; Chromosomes, Human, Pair 11; DNA-Binding Proteins; Female; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Radioimmunotherapy; Transcription Factors; Yttrium Radioisotopes | 2002 |
[Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases].
Topics: Breast; Breast Neoplasms; Gold Radioisotopes; Humans; Hypophysectomy; Neoplasms; Neoplasms, Second Primary; Yttrium; Yttrium Radioisotopes | 1961 |
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.
Topics: Antibodies, Monoclonal; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary; Radioimmunotherapy; Yttrium Radioisotopes | 2008 |